Medical diagnostics
Clinical laboratory tests are critical to diagnosing and managing patients. Accurate measurement of drug concentrations can help the healthcare provider to figure out the most effective dose and diagnose overdoses. New in vitro diagnostics and wearable technologies based on the proprietary Canatu CNT material and dry deposition process have the potential to revolutionize the diagnostics industry.
Canatu CNT electrodes offer highly repeatable electrochemical transducer platform for biosensor development. This platform can be tailored for select immobilization protocols ensuring high sensitivity for chosen redox reporters. The performance of Canatu platform is currently undergoing validation with real patient samples in early clinical studies.
Electrochemical sensors using Canatu CNT’s offer:
- High electrical conductivity and surface area
- High sensitivity and signal-to-noise ratio
- Proven scalability of production process
Electrochemical sensors
Canatu and FEPOD have developed a point-of-care assay for quantitative detection of paracetamol in finger-prick blood samples. This assay uses disposable test strips based on the Canatu CNT point-of-care sensing platform. The inherently large surface area, high conductivity, and tailorable surface chemistry, makes Canatu CNT films an ideal electrode material for electrochemical sensors. Photo © FEPOD
Lab on a strip
Opioid misuse and access to care continue to be key challenges. Painkillers are some of the most misused drugs. Every year, 15 million people misuse opioids in the EU and US, and more than 68,000 people in US alone die from opioid-involved overdoses. The economic cost of opioid crisis is 78,5 billion dollars annually in US.
Currently, there are no fast and reliable means for measuring opioid concentrations at the point of care. Simpler and inexpensive lab-level tests with rapid results are needed, to equip caregivers with better means to determine best patient care. Accurate and safe dosing of opioids is critical for safe patient care; to kill the pain effectively, to prevent dependency and to prevent lethal overdoses.
Canatu’s solution brings the medical laboratory anywhere, making sure saving lives is no longer about cost of care or lack of information.
Saving lives is no longer about cost of care or lack of information.
A market survey carried out by Canatu revealed that almost 70% of health care professionals would use rapid opioid sensors if they were approved for use by regulatory authorities.
Canatu advances point-of-care opioid sensors for immediate medical diagnostics with forerunner companies, research partners and a leading Finnish University Hospital, together transforming products for better tomorrows with nano carbon.
See video
We partner with forerunner companies ready to transform industries
Contact our specialist in medical diagnostics
Send us a message
Related content
The inherently large surface area, high conductivity and tailorable surface chemistry makes Canatu CNT an ideal electrode material for electrochemical sensors. See the product.
Canatu has a versatile platform for biosensor development. Electrochemical sensors using Canatu CNTs have the potential to provide resilient, accurate, reliable, and low-cost analysis in clinical, industrial, environmental, food safety and agricultural sectors. See the platform.
Electrochemical sensors for bedside blood concentration measurement progress to clinical studies. The new point-of-care measurement enables real-time detection of analgesics from blood without extensive sample treatment, improving test result wait time, cost and convenience. See press release.
Finnish ecosystem spurs diagnostics development. Canatu will develop a new hybrid electrochemical sensor for target detection and drug concentration measurement. See press release.
Canatu creates nano solutions for massive impact. We work with carbon, the most versatile material in the universe, and collaborate with other forerunner companies to make breakthrough innovations. See our company.
Canatu partners with forerunner companies, research partners and a leading Finnish University Hospital, together transforming products for better tomorrows with nano carbon. See how we collaborate for an impact.
